Sudan

Reimbursed Care Access

Sudan follows the UN drug-control framework and national narcotics legislation (Narcotic Drugs and Psychotropic Substances Act, 1994), which criminalises classical psychedelics and most psychotropic schedules; however ketamine is widely used and available as an essential anaesthetic in Sudanese hospitals. There is no public evidence of national regulatory approvals or public reimbursement pathways for specialized psychedelic medicines (e.g., esketamine, psilocybin, MDMA) — access is either routine medical use for ketamine or otherwise limited to criminalised status or research contexts.